Summary. In a population-based survey of 2,930 subjects, prevalence rates for obesity, Type 2 (non-insulin-dependent) diabetes mellitus, impaired glucose tolerance, hypertension, hypertriglyceridaemia, and hypercholesterolaemia were 54.3, 9.3, 11.1, 9.8, 10.3 and 9.2%, respectively. The prevalence, however, of each of these conditions in its isolated form (free of the other five) was 29.0% for obesity, 1.3% for Type 2 diabetes, 1.8% for impaired glucose tolerance, 1.5% for hypertension, 1.0% for hypertriglyceridaemia, and 1.7% for hypercholesterolaemia. Two-by-two associations were even rarer. The large differences in prevalence between isolated and mixed forms indicate a major overlap among the six disorders in multiple combinations. In the isolated form, each condition was characterized by hyperinsulinaemia (both fasting and 2 h after oral glucose), suggesting the presence of insulin resistance. In addition, in any isolated condition most of the variables categorising other members of the sextet were still significantly altered in comparison with 1,049 normal subjects. In the whole of the subjects who presented with one or another disorder (1,881 of 2,930 or 64%), marked fasting and post-glucose hyperinsulinaemia was associated with higher body mass index, waist:hip ratio, fasting and post-glucose glycaemia, systolic and diastolic blood pressure, serum triglycerides and total cholesterol levels, and with lower HDL-cholesterol concentrations (all p < 0.001). We conclude that (1) insulin sensitivity, glucose tolerance, blood pressure, body fat mass and distribution, and serum lipids are a network of mutually interrelated functions; and (2) an insulin resistance syndrome underlies each and all of the six disorders carrying an increased risk of coronary artery disease.
It has long been known that both hypertension and Type 2 (non-insulin-dependent) diabetes mellitus are often associated with overweight [1, 2] , and that hypertension is more prevalent among diabetic than non-diabetic individuals [3] . Hyperlipidaemia (high serum triglyceride or total cholesterol concentrations or both) is found with increased frequency in both diabetic [4] and hypertensive patients [5] . Thus, there seems to be a substantial overlap of disturbances of carbohydrate and lipid metabolism and of blood pressure in the general population, although, to our knowledge, a formal analysis of such clustering has not appeared in the literature.
Recently, it has been suggested that hyperinsulinaemia may be the common element accounting for the association of obesity, Type 2 diabetes, and hypertension [6] . Obesity and Type 2 diabetes are classic states of insulin resistance [7] , and recent evidence has shown that essential hypertension per se is often an insulin-resistant condition [8] . This has led Reaven [9] to hypothesise that insulin resistance aggregates with glucose intolerance, hypertension, and dyslipidaemia in a distinct syndrome (syndrome X).
Diabetes, hypertension, and hypercholesterolaemia are unquestioned risk factors for cardiovascular disease (CVD) [10] , whilst the evidence linking impaired glucose tolerance to CVD is less consistent [11] . The Framingham study has also established that high triglyceride levels, when coupled with low high-density-lipoprotein(HDL)-cholesterol concentrations, carry an increased risk of CVD [10] . Finally, recent data from a large population-based, follow-up study indicate that overweight, even of a minor degree, is an independent risk factor for ischaemic heart disease in women [12] . On the other hand, in two prospective epidemiologic studies [13, 14] plasma insulin concentration has emerged as an independent predictor of coronary heart disease. On these grounds, it is logical to suppose that the putative hyperinsulinaemia/insulin resistance syndrome may be associated with an increased risk of cardiovascular morbidity.
The present analysis of the San Antonio Heart Study database identifies and characterises an insulin resistance syndrome.
Subjects and methods

Subjects
The San Antonio Heart Study is a population-based study of diabetes and cardiovascular diseases in Mexican-Americans and non-Hispanicwhites. From 1984 to 1988 households from several types of San Antonio census groups were randomly sampled: low-income census tracts (95% Mexican-American); middle-income tracts (50% Mexican-American and 50% non-Hispanic white); and suburban census tracts (10% Mexican-American, 90% non-Hispanic white) [15] . Stratified random sampling was used in the middle-income and suburban census tracts to ensure the inclusion of approximately equal numbers of each ethnic group in the study sample. All men and nonpregnant women 25 to 64 years of age were eligible for the study.
Ethnicity was defined on the basis of a previously published algorithm which considered parental surnames and birthplaces, stated ethnicity of grandparents, and participant's preferred ethnic identity when it indicated a distinct national origin [16] . Persons who were identified as belonging to an ethnic group other than MexicanAmerican or non-Hispanic white are excluded from the present analysis. The study was approved by the Institutional Review Board of the University of Texas Health Science Center at San Antonio, and all subjects gave informed consent.
Procedures
Anthropometric measurements (height, weight, and waist/hip circumference ratio, WHR) were made with each participant wearing only underclothes and an examination gown [15] . Body mass index The inner circle represents the mean value of each of the 12 variables (listed along the radii) in 1,049 healthy individuals; such mean values are set to be 100%. The symbols are percent differences in each variable between the patients groups and healthy controls (i.e. mean group value/mean control value times 100, plotted in log scale along the radii corresponding to the variable). Filled symbols and full lines identify the group of all subjects with obesity or hypertension; empty symbols and broken lines identify the subgroup of subjects with isolated obesity or hypertension (see the text for the definition of isolated). The variable in the box is the categorical (or coding) variable for the disease. BMI = body mass index; WHR = waist/hip ratio; Fast. G = fasting plasma glucose concentration; 2-hr G = plasma glucose concentration 2 h after an oral glucose load; Fast. I = fasting plasma insulin concentration; 2-hr I = plasma insulin concentration 2 h after an oral glucose load; TG = serum triglyceride level; Chol = serum total cholesterol level; HDL = serum high-density-lipoprotein cholesterol level; DBP = diastolic blood pressure; SBP = systolic blood pressure (BMI) was calculated as weight (in kg) divided by height (in meters) squared. Obesity was defined as a BMI > 27 kg/m 2 ( > 26 kg/m 2 for women) [17] . Blood pressure was measured on the right arm of the seated participant following at least a 5-min rest using a random-zero sphygmomanometer (Hawksley-Gelman, London, UK). Three readings were recorded of the systolic (first phase) and diastolic (fifth phase) measured to the nearest even digit, and the subject's blood pressure was defined as the average of the second and third reading. Hypertension was defined according to the Hypertension Detection and Follow-up criteria (diastolic blood pressure > 95 mm Hg and/or currently taking antihypertensive medication) [181.
Blood specimens were obtained following a 12-14 h fast for serum lipid, lipoprotein, and insulin and plasma glucose determinations. A 75-g glucose-equivalent load (Coladex or Orangedex, Cus-tom Laboratories, Baltimore, Md., USA) was then administered, and blood specimens were obtained 2 h later for plasma glucose and insulin measurements. Methods for measurement of glucose, lipid, lipoprotein, and insulin have been published previously [15] . Diabetes was diagnosed according to the criteria of the World Health Organization (WHO) (fasting plasma glucose levels _> 7.8 mmol/1 or 2nd h plasma glucose _>ll.lmmol/1 [i9]. In previous reports, we have used National Diabetes Data Group (NDDG) criteria [2] . However, since the NDDG criteria do not have an unambiguous category for impaired glucose tolerance, we utilised the WHO criteria in the present report. The concordance between WHO and NDDG criteria for diagnosing diabetes in the San Antonio Heart Study is 98%. Subjects who did not meet these criteria but who were currently being treated with oral antidiabetic agents or insulin were also considered to have diabetes. Impaired glucose tolerance (IGT) was defined as a fasting plasma glucose <7.Smmol/1 and a 2nd h plasma glucose between 7.8 and 11.1 mmol/1. Hypertriglyceridaemia was defined as a serum triglyceride concentration > 2.90 mmol/1, and hypercholesterolaemia as a serum total cholesterol concentration > 6.50 mmol/1.
Statistical analysis
Plasma insulin, glucose and triglyceride concentration values were log transformed to improve skewness. Group means were compared with the use of Student s t-test. Simultaneous adjustment for other variables was carried out by multiple linear regression. Data are given as mean + SEM.
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Results
The population sample consisted of 2,930 subjects (43% men, 68% Mexican-American), with a mean age of 42.9 years. Over one-half of the population sample was obese; each of the other five conditions was present in roughly 10% ofallsubjects ( Table 1 ). Only36% of all study subjects were 'normal' in that they were free of all six disorders. The crude prevalence rates of the six conditions in their'pure' or isolated form, i. e. associated with none of the other five, were much lower than the overall prevalence rates, by 50% in the case of obesity, 5-10 fold in the case of the others (Table 1) . Two-by-two associations of isolated forms were even rarer, and in each case less frequent than expected by chance ( Table 1) . As a result, large proportions -ranging from 17% for obesity to 56% for hypertension-of the cases of each of the six conditions occurred in combination with three or more of the others. When the six groups of patients consisting of all cases with a condition were compared with the respective subgroups in which the disease was present in isolation ( Figs. 1-3) , the profile of the 12 measured (physiological and metabolic) variables was still qualitatively abnormal in the 'isolated' condition subgroups. The clinical characteristics of these latter are shown in Table 2 together with those of the normal subjects, while Table 3 lists the corre- sponding metabolic me asurements. Differences in age, sex or ethnicity ratio, and body mass index were present between each patient subgroup and the control subjects ( Table 2 ). The waist/hip ratio was significantly higher than normal in obese (p < 0.005), diabetic (p < 0.01), glucoseintolerant (p < 0.02), and hypertensive (p = 0.02), but not in hypertriglyceridaemic or hypercholesterolaemic, patients. Because age, gender, ethnic origin, and body mass were all found to have a significant statistical influence on one or more of the metabolic variables (data not shown), comparisons between each patient subgroup and the control population were carried out after adjusting, by multiple linear regression, for age, sex, ethnicity, and BMI. The results are reported in Table 4 in terms of percent deviations from the mean reference values. They show that, even after the adjustments, each of the six isolated condi-419 tions was characterised by significant changes in several of the metabolic variables in addition to the defining variable for the condition itself. Thus, raised blood pressure was present also in 'pure' diabetic, IGT, or obese subjects, while increased fasting and 2nd h plasma glucose concentrations also occurred in 'pure' obese or hypertensive subjects. In particular, hyperinsulinaemia, fasting or post-glucose, was found in all patient groups (although in pure hypercholesterolaemia the adjusted difference from control subjects fell just short of full statistical significance,p = 0.11). When the 1,881 subjects with one or another disease combination (the 'insulin resistant' group) were compared with the 1,049 control subjects, all of the clinical and metabolic variables were significantly above normal (or below, in the case of serum HDL-cholesterol concentrations) (Fig. 4) . Adjusting for age, sex, ethnicity, and BMI did not alter either the size or the level of statistical significance of the differences (Table 5 ).
In the control group, numerous simple correlations were present among the measured variables, clinical and metabolic alike. In particular, when the fasting or postglucose plasma insulin concentration was set to be the dependent variable in a multiple regression model, 23 and 53%, respectively, of the variance was explained by the other 13 measured variables (p < 0.001). In the 'insulin resistant' group, 50% of the variability of fasting insulin, and 57% of that of post-glucose insulin, was statistically explained by the other measured variables (p < 0.001).
Discussion
The first result that stands out in the present analysis is the very high degree of overlap among the six conditions considered (obesity, Type 2 diabetes, hypertension, impaired glucose tolerance, hypertriglyceridaemia, and hyper- = fasting plasma glucose; 2h-PG -2-h plasma glucose; FPI = fasting plasma insulin; 2h-PI = 2-h plasma insulin; TG = serum triglycerides; Chol = serum total cholesterol; HDL = serum HDL-cholesterol; SBP = systolic blood pressure; DBP = diastolic blood pressure [15] . Since obesity, especially of the truncal variety, also is particularly frequent in MexicanAmericans [17] , the results of the present analysis may not fully extend to other populations. Also striking is the observation that simple (two-bytwo) associations were all rarer than predicted by chance alone; this sort of spurious 'protection' against occurrence of two conditions together was actually the result of the high prevalence of triple or multiple combinations (Table 1) . Thus, for all conditions but obesity, occurring as an isolated case in the cluster was an exceedingly infrequent event at the population level. One immediate practical corollary of these findings is that diagnosing any one of the six conditions in question should be sufficient indication to screen for the other five. Because of the extensive overlap, it was not surprising to find that each of the six conditions was characterized by multiple abnormalities (Figs. 1-3 ). More importantly, the analysis of the subgroups in which each condition was present alone revealed that, even in these isolated cases each categorical abnormality (e. g., blood pressure in hypertension) was accompanied by significant changes in several of the metabolic variables classifying other members of the sextet (after adjusting for age, gender and ethnic ratio, and BMI). Thus, lean, normotensive, normolipidaemic diabetic patients still had a significantly lower HDLcholesterol concentration and an increased systolic blood E. Ferrannini et al.: The insulin resistance syndrome pressure value; lean, non-diabetic, normolipidaemic hypertensive patients also had slight fasting hyperglycaemia and hyperlipidaemia when compared with the control subjects (Table 4) . These results, and the fact that the 12 measured variables showed a high degree of interrelatedness even in the group of healthy control subjects, suggest that the network of connections among the six conditions may simply be an amplification of normal links among the underlying physiological functions [5] . The physiological basis of several such relationships is well established. For example, a rise in piasma glucose levels can directly result from tissue refractoriness to insulin action on glucose uptake; elevated glycaemia then elicits a heightened insulin secretory response, which in turn is a stimulus for hepatic VLDL-triglyceride production [20] [21] [22] . Also, hyperinsulinaemia may raise blood pressure by a variety of mechanisms including renal sodium conservation and adrenergic activation [23] . If, then, the physiologic system explored by these parameters is indeed a network, pulling one element out of the normal boundaries will act upon the connecting arms to drag other neighbouring elements into the 'abnormal' domain. For example, if a strong genetic pressure drives plasma glucose into the diabetic range, blood pressure and lipids will trail behind, occasionally crossing the diagnostic <0.0001 The comparison with the control group is made after adjusting for age, sex, ethnicity, and BMI, and calculated at the mean population age (43 years) and BMI (27.9 kg/m 2) for a male Mexican-Americansubject. M/F = male/female ratio; MA/NHW = Mexican-American/non-Hispanic white; BMI = body mass index; WHR = waist/hip ratio; SBP = systolic blood pressure; DBP = diastolic blood pressure threshold of clinical hypertension and dyslipidaemia. Thus, on a priori grounds it is highly unlikely that any of this kindred of disorders will occur in true isolation, i.e. with no changes (or opposite changes) in the tied metabolic/haemodynamic functions.
The other major finding of this study is that, while insulinaemia itself is not a classification variable for any disease, hyperinsulinaemia, fasting or post-glucose, was present in all the subgroups of isolated conditions. It was the common denominator of the sextet. Under most circumstances, a raised plasma insulin concentration implies the presence of insulin resistance, and, in fact, represents an adaptive response to the reduced sensitivity to the hormone [24] . Previous studies using the euglycaemic insulin clamp technique [25] have shown that insulin resistance is present in non-diabetic, normotensive obese subjects [26] , in lean, normotensive patients with Type 2 diabetes [27] or impaired glucose tolerance [28, 29] , in lean, normotensive hypertriglyceridaemic subjects [30] , and in lean, nondiabetic, normolipidaemic hypertensive patients [8, 31] . In these highly selected patient groups, the insulin resistance has been thought of as primary [9] . Direct evidence that pure, isolated hypercholesterolaemia may be associated with insulin resistance is lacking, but the data in Table 4 suggest that this might be the case. Thus, at least five of the six conditions considered here have already entered the list of primary insulin resistant states in humans. Therefore, the present data on hyperinsulinaemia very likely illustrate the relationship of insulin resistance with the physiological and metabolic changes found in the member conditions of the sextet. It is legitimate to collectively indicate the sextet as a primary insulin resistance syndrome (Fig. 4) , in which different features (e. g., hyperglycaemia or high blood pressure) dominate the clinical picture in different patients. This concept is an extension of the insulin resistance syndrome hypothesised by Reaven [9] , and alluded to by Lind et al. [32] , and certainly is not exhaustive: other disorders with genetic imprint, insulin resistance and atherogenic potential may be included.
The question then arises: is insulin resistance one common result of the six conditions (e. g., via hyperglycaemia in Type 2 diabetes, or high blood pressure in hypertension), or is it a basic cellular defect, parent to the conditions? Available evidence appears to be insufficient to answer this question. Some information would favour a primacy of insulin resistance. Thus, at least in nondiabetic Pima Indians, in vivo insulin action is a familial characteristic [33] . Furthermore, non-diabetic relatives of Type 2 diabetic patients present hyperinsulinaemia [34] and insulin resistance [35] , and hyperinsulinaemia predicts the subsequent development of Type 2 diabetes [36] . Parental history of Type 2 diabetes is associated with higher prevalence of hypertension and lipid abnormalities in non-diabetic probands [37] . Hyperinsulinaemic, but otherwise healthy, individuals have higher plasma glucose and lipid levels and blood pressure values [38] . In at least one variant of familial dyslipidaemic hypertension, hyperinsulinaemia is found that is not fully explained by obesity [39] . On the other hand, insulin resistance can be entirely acquired -as presumably are many cases of obesity in-421 duced by excess caloric intake -and yet display the full range of associated abnormalities of glucose and lipid metabolism and blood pressure. The present analysis of cross-sectional data cannot offer any clue as to the nature of the observed associations among diseases or the relation of each of them to insulin resistance. Genetic heterogeneity, environmental factors, and gene-environment interactions are known to determine the natural history of obesity, Type2 diabetes, hypertension, and dyslipidaemias [40] [41] [42] [43] [44] . Their multiple associations may likewise reflect true genetic linkage, cause-effect relationships, or both. At present, it seems both accurate and prudent to state that the presence of insulin resistance in the sextet can have a variable value -of a predisposing or aggravating factor-in the different member diseases and, possibly, within the affected individuals of each disease.
Whatever the case, the general pattern of abnormalities in the insulin resistant group (Fig. 4) is a highly atherogenic risk profile, in support of the contention that this syndrome is a precursor of CVD. Longitudinal studies are needed to address what appears to be the crucial issue: is an insulin resistant individual 'bound' to develop a string of abnormalities ultimately leading to CVD ?
